3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Tumor Lysis Syndrome
1
Lymphoma
1
Leukemia
1
Inflammation
1
Hyperuricemia
1
Gout
1
Cardiovascular Diseases
1
Arthritis
1
Interventions
rasburicase
8
Urate Oxidase
4
Allopurinol
3
venetoclax
1
obinutuzumab
1
alvocidib
1
Uric Acid
1
Pegloticase
1
Oxidoreductases
1
Lenalidomide
1
Febuxostat
1
Carbamates
1
Bendamustine Hydrochloride
1
Amides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Tumor Lysis Syndrome
×
Febuxostat
×
Clear all
NCT01724528
2014-11-03
FLORENCE
Menarini Group
Phase 3
Completed
346 enrolled
16 charts